Form C-AR - Annual Report:
SEC Accession No. 0001670254-24-000459
Filing Date
2024-04-26
Accepted
2024-04-26 17:04:06
Documents
11
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C-AR  
1 primary_doc.xml C-AR 3663
2 document_1.pdf EX-99 7932285
3 document_2.pdf EX-99 10138301
4 document_3.pdf EX-99 7196479
5 document_4.pdf EX-99 11307933
6 document_5.pdf EX-99 11318661
7 document_6.pdf EX-99 1956142
8 document_7.pdf EX-99 1949773
9 document_8.pdf EX-99 603867
10 document_9.pdf EX-99 1173792
11 documents_list.htm EX-99 123
  Complete submission text file 0001670254-24-000459.txt   71068201
Mailing Address 223 WALL STREET, #130 HUNTINGTON NY 11743
Business Address 223 WALL STREET, #130 HUNTINGTON NY 11743 201-400-8083
SEN-JAM PHARMACEUTICAL INC. (Filer) CIK: 0001802249 (see all company filings)

EIN.: 822750291 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C-AR | Act: 33 | File No.: 020-29297 | Film No.: 24885023